|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturities available for sale (''AFS''), at fair value (amortized cost: 2018 - $29,689,322; 2017 - $30,157,581) | ||||||||||||||||||||
| Equity securities, at fair value (cost: 2017 - $638,455; 2016 - $996,610) | ||||||||||||||||||||
| Short-term investments AFS, at fair value (amortized cost: 2018 - $623,158; 2017 - $816,638) | ||||||||||||||||||||
| Total investments available for sale | ||||||||||||||||||||
| Fixed maturities trading, at fair value (amortized cost: 2018 - $1,965,372; 2017 - $1,946,501) | ||||||||||||||||||||
| Short-term investments, at fair value (amortized cost: 2015, $70,883; 2014, nil) | ||||||||||||||||||||
| Short-term investments trading, at fair value (amortized cost: 2018 - $5,777; 2017 - $14,969) | ||||||||||||||||||||
| Total investments trading | ||||||||||||||||||||
| Equity securities, at fair value (cost: 2018 - $586,220; 2017 - $638,455) | ||||||||||||||||||||
| Investments in affiliates | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Deferred acquisition costs and value of business acquired | ||||||||||||||||||||
| Ceded unearned premiums | ||||||||||||||||||||
| Premiums receivable | ||||||||||||||||||||
| Reinsurance balances receivable | ||||||||||||||||||||
| Unpaid losses and loss expenses recoverable | ||||||||||||||||||||
| Receivable from investments sold | ||||||||||||||||||||
| Goodwill and other intangible assets | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Unpaid losses and loss expenses | ||||||||||||||||||||
| Deposit liabilities | ||||||||||||||||||||
| Future policy benefit reserves | ||||||||||||||||||||
| Funds withheld on GreyCastle life retrocession arrangements (net of future policy benefit reserves recoverable: 2018 - $2,971,191; 2017 - $3,191,584) | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Notes payable and debt | ||||||||||||||||||||
| Reinsurance balances payable | ||||||||||||||||||||
| Payable for investments purchased | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Equity: | ||||||||||||||||||||
| Authorized shares, 999,990,000, par value $0.01; common shares issued and outstanding (2018 - 258,780,274; 2017 - 256,033,895) | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Shareholders' equity attributable to XL Group Ltd | ||||||||||||||||||||
| Non-controlling interest in equity of consolidated subsidiaries | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
